Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Avera McKennan Hospital & University Health Center
Memorial Sloan Kettering Cancer Center
University of Nebraska
Memorial Sloan Kettering Cancer Center
University of Salamanca
University Health Network, Toronto
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Stanford University
Taproot Health
Sanguine Biosciences
Stanford University
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Blue Note Therapeutics
Weprom
Seoul National University Hospital
University of Wisconsin, Madison
CureOne
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Novartis
University of Washington
Stanford University
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center